Resmed Inc. Stock
Price
Target price
€236.20
€236.20
0.680%
1.6
0.680%
€251.96
10:59 / Tradegate
WKN: 895878 / Symbol: RMD / Name: ResMed / Stock / Healthcare Equipment & Supplies / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Resmed Inc. Stock
Resmed Inc. gained 0.680% compared to yesterday.
We see a rather positive sentiment for Resmed Inc. with 20 Buy predictions and 1 Sell predictions.
As a result the target price of 251 € shows a slightly positive potential of 6.27% compared to the current price of 236.2 € for Resmed Inc..
Pros and Cons of Resmed Inc. in the next few years
Pros
?
S********** s********
?
B****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Resmed Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Resmed Inc. | 0.680% | -4.673% | -2.777% | 5.819% | 5.533% | 6.250% | 55.364% |
| Veeva Systems A | -0.870% | -6.107% | -5.142% | 17.713% | 13.484% | 33.635% | -6.659% |
| Thermo Fisher Scientific Inc. | -0.270% | 0.379% | 6.023% | -23.737% | -15.040% | -23.421% | 16.520% |
| Waters Corp. | -1.240% | 0.155% | 2.707% | -17.148% | -27.447% | -13.161% | 44.944% |
Comments
ResMed Inc. (NYSE: RMD) was upgraded by analysts at William Blair to a "strong-buy" rating.
Show more
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Mizuho from $270.00 to $290.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at Royal Bank Of Canada from $294.00 to $300.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for RMD provided by MarketBeat
News
ResMed: A Mixed Bag for Investors Amid Rising Competition
Explore the exciting world of ResMed (NYSE: RMD) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential
